Literature DB >> 10463582

Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.

D Feldser1, F Agani, N V Iyer, B Pak, G Ferreira, G L Semenza.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) activates transcription of genes encoding glucose transporters, glycolytic enzymes, vascular endothelial growth factor, and other proteins involved in O2 homeostasis and tumor progression. The expression and transcriptional activity of the HIF-1alpha subunit is regulated by the cellular O2 concentration. We demonstrate that insulin, insulin-like growth factor (IGF)-1, and IGF-2 induce expression of HIF-1alpha, which is required for expression of genes encoding IGF-2, IGF-binding protein (IGFBP)-2 and IGFBP-3. These data provide a novel mechanism by which HIF-1alpha overexpression may occur in tumor cells and contribute to an autocrine growth factor loop.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463582

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  180 in total

1.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

Authors:  K L Talks; H Turley; K C Gatter; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.

Authors:  E Laughner; P Taghavi; K Chiles; P C Mahon; G L Semenza
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Rapidly involuting congenital haemangioma (RICH) of the liver.

Authors:  Derek Roebuck; Neil Sebire; Eldon Lehmann; Alex Barnacle
Journal:  Pediatr Radiol       Date:  2012-03

4.  Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.

Authors:  Madhuri Ramanathan; Grace Pinhal-Enfield; Irene Hao; Samuel Joseph Leibovich
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

5.  Myeloid cells in infantile hemangioma.

Authors:  Matthew R Ritter; John Reinisch; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

6.  Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis.

Authors:  Feng Wang; Shu Shun Li; Ralf Segersvärd; Lisa Strömmer; Karl-Gösta Sundqvist; Jan Holgersson; Johan Permert
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia.

Authors:  Huafeng Zhang; Marta Bosch-Marce; Larissa A Shimoda; Yee Sun Tan; Jin Hyen Baek; Jacob B Wesley; Frank J Gonzalez; Gregg L Semenza
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

Review 8.  The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Kathy Q Cai; Michael F Ochs; Burton Eisenberg; Min Huang; Margaret von Mehren; Andrew K Godwin
Journal:  Cell Cycle       Date:  2008-10-07       Impact factor: 4.534

9.  Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Authors:  Ming Yin; Xiaoxiang Guan; Zhongxin Liao; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-30       Impact factor: 4.060

10.  Mid- to late term hypoxia in the mouse alters placental morphology, glucocorticoid regulatory pathways and nutrient transporters in a sex-specific manner.

Authors:  J S M Cuffe; S L Walton; R R Singh; J G Spiers; H Bielefeldt-Ohmann; L Wilkinson; M H Little; K M Moritz
Journal:  J Physiol       Date:  2014-05-06       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.